Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Colorectal Neoplasms × Tirzepatide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Gastrointestinal 1

Conditions

Prostatic Neoplasms 2 Obesity 2 Diabetes Mellitus 2 Weight Loss 1 Overweight 1 Opioid-Related Disorders 1 Lymphoma, Follicular 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

Bevacizumab 65 Fluorouracil 45 Cetuximab 43 Oxaliplatin 33 Leucovorin 33 pembrolizumab 32 Irinotecan 27 Folfox protocol 21 Specimen Handling 18 HMPL-013 18 Capecitabine 18 Blood Specimen Collection 16 trifluridine tipiracil drug combination 15 Magnetic Resonance Spectroscopy 13 regorafenib 12 Biopsy 12 Panitumumab 11 Cisplatin 11 Trifluridine 10 Nivolumab 10 Gemcitabine 10 Carboplatin 10 Interviews as Topic 9 IFL protocol 9 Drug Therapy 9 Colonoscopy 9 encorafenib 8 Standard of Care 8 tislelizumab 7 sintilimab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07095517 2026-02-27

PROSPECT

Massachusetts General Hospital

Phase 1 Recruiting

GastrointestinalOther

Obesity, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡